「adrenergic」の共起表現一覧(1語右で並び替え)

adrenergic

1語右で並び替え

該当件数:83件

  • odafinil possesses greater selective alpha-1 adrenergic activity than adrafinil without the side eff
  • If the amine on the Adrenergic agent has a substituent bigger than a tertia
  • stituted phenethylamines are known to act as adrenergic agents (including adrenergic uptake inhibito
  • vity or idiosyncrasy to their components, to adrenergic agents or to other drugs of similar chemical
  • The pharmacologic effects of beta adrenergic agonist drugs, such as orciprenaline, are at
  • ptor agonist and also has some serotonin and adrenergic agonist effects, as well as some anticholine
  • Adrenergic agonists or withdrawal from alpha blockers (
  • It has the opposite effect as adrenergic agonists.
  • ine, and similarly to it, has effects on the adrenergic and dopaminergic systems.
  • ne and dopamine and therefore an increase in adrenergic and dopaminergic neurotransmission.
  • compensatory changes at dopamine, serotonin, adrenergic and histamine receptor sites in the central
  • An Adrenergic antagonist is a pharmaceutical substance tha
  • of beta-1 (ADRB1) may affect the response to adrenergic beta-antagonist treatment of heart failure.
  • cells), Ca2+ channel antagonistic action, α1 adrenergic blockade and others.
  • Guanadrel is a postganglionic adrenergic blocking agent.
  • Pirbuterol (trade name: Maxair) is a beta-2 adrenergic bronchodilator used in the treatment of asth
  • n primarily by increasing catecholaminergic ( adrenergic, dopaminergic) and histaminergic activity in
  • indicate that etilefrine has both β1 and α1 adrenergic effects in man.
  • ke inhibitor and has negligible affinity for adrenergic, histaminergic, and muscarinic receptors.
  • hypotension) which is followed by sustained adrenergic hyperactivity (hypertension, tachycardia, an
  • Adrenergic means "having to do with adrenaline (epineph
  • or a variety of dopaminergic, serotonergic, adrenergic, muscarinic or cannabinoid receptors and doe
  • ter release from sympathetic nerves and from adrenergic neurons in the central nervous system.
  • Effects on the body include cholinergic, adrenergic, opioid and nitric oxide donating actions, a
  • The adrenergic phase but not the cholinergic phase is a dos
  • Adrenergic receptor
  • The Adrenergic receptor Pathways
  • Adrenergic receptor agonist
  • Adrenergic receptor antagonist
  • Alpha-1 adrenergic receptor
  • It is a subtype of the adrenergic receptor family.
  • ICI-118,551 is a selective beta-2 (β2) adrenergic receptor antagonist.
  • Beta-3 adrenergic receptor has been shown to interact with Src
  • Beta adrenergic receptor kinase-2 appears to affect dopamine
  • ine is a nonselective agonist of the alpha-1 adrenergic receptor (α1-AR), and an antagonist to the a
  • The alpha-2A adrenergic receptor (α2A adrenoceptor), also known as A
  • Overall, the beta adrenergic receptor kinase 2 has 85% amino acid similar
  • Systemic Alpha-1 adrenergic receptor antagonists have been implicated in
  • (steps 1) Upon stimulation of the Beta adrenergic receptor by epinephrine, Gs will be activate
  • Beta adrenergic receptor kinase has been shown to interact w
  • is a cardiotonic drug which acts as a Beta-1 adrenergic receptor agonist.
  • The alpha-2B adrenergic receptor (α2B adrenoceptor), is a G-protein
  • The alpha-1 (α1) adrenergic receptor is a G protein-coupled receptor (GP
  • Beta adrenergic receptor kinase (also referred to as βARK or
  • It acts as both a selective α2 adrenergic receptor antagonist, and an antagonist for t
  • ent and selective antagonist for the Alpha-1 adrenergic receptor subtype α1B.
  • Adrenergic receptor antagonist, subtypes α2a and α2c: c
  • The beta adrenergic receptor kinase-2 was cloned from mice and r
  • It is an alpha-1 adrenergic receptor blocker that inhibits the binding o
  • , did not find that the gene coding for beta adrenergic receptor kinase-2 was linked to schizophreni
  • he NMDA antagonist tiletamine or the alpha-2 adrenergic receptor agonist xylazine, depending on what
  • a2A-adrenoceptor (also known as the alpha-2A adrenergic receptor) has been shown to improve working
  • t acts as a selective antagonist for the α2B adrenergic receptor, and has been useful for distinguis
  • research to understand the action of the β2 adrenergic receptor, as few other specific antagonists
  • , GAB1, MST1R, DNM1, Huntingtin, Src, Beta-2 adrenergic receptor, VAV2, ADAM15, RAPGEF1, VAV1, HER2/
  • onidine, it is an agonist at the α2 class of adrenergic receptor.
  • which acts as a selective agonist for the β3 adrenergic receptor.
  • nist at both the 5-HT1A receptor and the α2C adrenergic receptor.
  • which acts as a selective agonist for the β3 adrenergic receptor.
  • of drugs that bind selectively to the beta-1 adrenergic receptor.
  • 2 dopamine receptor and antagonist at the α1 adrenergic receptor.
  • fect on heart muscle, when binding to beta-1 adrenergic receptors on this tissue.
  • Beta adrenergic receptors are involved in the epinephrine- a
  • regulated by norepinephrine (noradrenaline) ( adrenergic receptors), whereas parasympathetic systems
  • thylclonidine is an irreversible agonist for adrenergic receptors, in particular alpha1B, D, C and a
  • ated via a partial agonist action at Alpha-2 adrenergic receptors, and TDIQ has been suggested as a
  • y blocking a variety of receptors, including adrenergic receptors, dopamine receptors, histamine rec
  • It stimulates adrenergic receptors.
  • It has no effect on alpha or beta adrenergic receptors.
  • nzamine forms a permanent covalent bond with adrenergic receptors.
  • metic that nonselectively agonizes α1 and α2 adrenergic receptors.
  • t also interacts centrally with dopamine and adrenergic receptors.
  • upling in the rat parotid gland and at alpha adrenergic receptors.
  • tivated through protein receptors such as α1 adrenergic receptors.
  • hilic side-chain that binds to an exosite on adrenergic receptors.
  • oson vasodilates but does not stimulate beta adrenergic receptors.
  • mals, suggesting stimulation of both α and β adrenergic receptors.
  • de, where they can come into contact with β2 adrenergic receptors.
  • Adrenergic reuptake inhibitor
  • and thereby rendering it less responsive to adrenergic stimulation ).
  • ppear to be mediated by the dopaminergic and adrenergic systems.
  • It localizes to adrenergic tissue and thus can be used to identify the
  • Adrenergic transporter